Scientists discover irreversible peptide inhibitors for undruggable cancer target

FHS
March 20, 2025
11:46 am

For the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously “undruggable” cancer protein target, permanently blocking it.

Khosla Ventures leads $38M seed round for organoid startup Vivodyne

Khosla Ventures is leading a seed round for a new biotech that aims to use artificial intelligence to jump into the world of organoids. Vivodyne

November 23, 2023

Web-based self-help program proves effective in treating binge eating disorder

Study shows that web-based cognitive behavioral self-help interventions effectively reduce binge eating episodes and improve overall well-being in individuals with binge eating disorder (BED).

May 20, 2024

False-Positive Mammograms May Discourage Subsequent Screenings

Women who received false-positive mammography results were less likely to return for screening, especially if they received recommendations for short-interval follow-up or biopsy, according to

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.